Modern Healthcare: The Trump administration's bold proposal to peg Medicare Part B drug payments to the much lower prices paid in other advanced countries surprised many. But veteran policywatchers say they'd be stunned if the plan goes anywhere given pharma's deep pockets, congressional Republicans' coolness to the proposal and congressional Democrats' skepticism.
Meanwhile, physician and patient advocacy groups, which helped kill a somewhat similar Obama administration proposal two years ago, were guarded in their reactions pending release of further details about President Donald Trump's plan.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now